Recombinant Chicken CTSD
|Product Overview :||Recombinant Chicken CTSD full length or partial length protein was expressed.|
- Gene Information
- Related Products
|Source :||Mammalian Cells|
|Form :||Liquid or lyophilized powder|
|Endotoxin :||< 1.0 eu per μg of the protein as determined by the LAL method.|
|Notes :||This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.|
|Storage :||Store it at +4 oC for short term. For long term storage, store it at -20 oC～-80 oC.|
|Storage Buffer :||PBS buffer|
|Gene Name :||CTSD cathepsin D [ Gallus gallus (chicken) ]|
|Official Symbol :||CTSD|
|Gene ID :||396090|
|Protein Refseq :||NP_990508|
|UniProt ID :||Q05744|
|◆ Recombinant Protein|
|CTSD-877H||Recombinant Human CTSD Protein, His-tagged||+Inquiry|
|CTSD-2752H||Recombinant Human CTSD Protein, His (Fc)-Avi-tagged||+Inquiry|
|Ctsd-2369M||Recombinant Mouse Ctsd Protein, His-tagged||+Inquiry|
|CTSD-786H||Recombinant Human CTSD Protein, His-tagged||+Inquiry|
|CTSD-913R||Recombinant Rhesus Macaque CTSD Protein, His (Fc)-Avi-tagged||+Inquiry|
|◆ Native Protein|
|CTSD-27858TH||Native Human CTSD||+Inquiry|
|CTSD-26411TH||Active Native Human Cathepsin D protein||+Inquiry|
|CTSD-1648H||Active Native Human Cathepsin D||+Inquiry|
|CTSD-3023MCL||Recombinant Mouse CTSD cell lysate||+Inquiry|
|CTSD-1735HCL||Recombinant Human CTSD cell lysate||+Inquiry|
|◆ Assay kits|
|Kit-0264||Cathepsin D Inhibitor Screening Kit||+Inquiry|
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Q&As (6)Ask a question
There is an association between CTSD proteins and cognitive function. In some neurodegenerative diseases, abnormal accumulation and deposition of CTSD proteins may affect neuronal signaling and synaptic function, leading to a decline in cognitive function.
In some neurodegenerative diseases, levels of the CTSD protein may change. For example, people with Alzheimer's disease may have elevated levels of the CTSD protein. These changes may help in the diagnosis of the disease and in the assessment of the course of the disease.
For people with cognitive decline, their CTSD protein levels can be assessed by a blood or cerebrospinal fluid sample. This evaluation can help doctors understand whether the cause of cognitive decline is related to a neurodegenerative disease.
It is currently no treatment that directly targets the CTSD protein. However, some medications can reduce symptoms of neurodegenerative diseases, such as cholinesterase inhibitors such as donepezil, which can increase acetylcholine levels in synapses, which can improve cognitive function.
People with Parkinson's disease may have reduced levels of the CTSD protein. This decrease may be associated with neuronal death and impaired synaptic function. In addition, CTSD protein may also be associated with motor symptoms in patients with Parkinson's disease.
CTSD proteins play a role in Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases. It may change in these diseases, leading to structural alterations and impaired signaling of neuronal synapses.
Customer Reviews (3)Write a review
Good at western-blot experiments. -
In experiments, the biocompatibility performed well. -
The experimental conditions are broad, and the experimental results are accurate and repeatable. -
Ask a Question for All CTSD Products
Required fields are marked with *
My Review for All CTSD Products
Required fields are marked with *